{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:03:38Z","timestamp":1787321018346,"version":"build-2736575974"},"reference-count":47,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:p>INTRODUCTION: The Objective was to investigate the incidence of lymphedema after breast cancer treatment and to analyze the risk factors involved in a tertiary level hospital. METHODS: Prospective longitudinal observational study over 3 years post-breast surgery. 232 patients undergoing surgery for breast cancer at our institution between September 2013 and February 2018. Sentinel lymph node biopsy (SLNB) or axillary lymphadenectomy (ALND) were mandatory in this cohort. In total, 201 patients met the inclusion criteria and had a median follow-up of 31 months (range, 1\u201354 months). Lymphedema was diagnosed by circumferential measurements and truncated cone calculations. Patients and tumor characteristics, shoulder range of motion limitation and local and systemic therapies were analyzed as possible risk factors for lymphedema. RESULTS: Most cases of lymphedema appeared in the first 2 years. 13.9% of patients developed lymphedema: 31% after ALND and 4.6% after SLNB (p &lt;\u00a00.01), and 46.7% after mastectomy and 11.3% after breast-conserving surgery (p &lt;\u00a00.01). The lymphedema rate increased when axillary radiotherapy (RT) was added to radical surgery: 4.3% for SLNB alone, 6.7% for SLNB + RT, 17.6% for ALND alone, and 35.2% for ALND + RT (p &lt;\u00a00.01). In the multivariate analysis, the only risk factors associated with the development of lymphedema were ALND and mastectomy, which had hazard ratios (95% confidence intervals) of 7.28 (2.92\u201318.16) and 3.9 (1.60\u20139.49) respectively. CONCLUSIONS: The main risk factors for lymphedema were the more radical surgeries (ALND and mastectomy). The risk associated with these procedures appeared to be worsened by the addition of axillary radiotherapy. A follow-up protocol in patients with ALND lasting at least two years, in which special attention is paid to these risk factors, is necessary to guarantee a comprehensive control of lymphedema that provides early detection and treatment.<\/jats:p>","DOI":"10.3233\/bd-210043","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T11:51:44Z","timestamp":1631879504000},"page":"97-108","source":"Crossref","is-referenced-by-count":22,"title":["Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy"],"prefix":"10.1177","volume":"41","author":[{"given":"S.","family":"Salinas-Huertas","sequence":"first","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Luzardo-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"V\u00e1zquez-Gallego","sequence":"additional","affiliation":[{"name":", Hospital Clinic, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pernas","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Falo","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Pla","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gil-Gil","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Beranuy-Rodriguez","sequence":"additional","affiliation":[{"name":", Hospital de la Santa Creu i Sant Pau, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"P\u00e9rez-Montero","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gomila-Sancho","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Manent-Molina","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Arencibia-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gonzalez-Pineda","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tormo-Collado","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ort\u00ed-Asencio","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Terra","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martinez-Perez","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mestre-Jane","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Campos-Varela","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jaraba-Armas","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ben\u00edtez-Segura","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, , , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Campos-Delgado","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Fern\u00e1ndez-Montol\u00ed","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Valverde-Alc\u00e1ntara","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Campos","sequence":"additional","affiliation":[{"name":", Institut Catal\u00e0 d\u2019Oncolog\u00eda, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Guma","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ponce-Sebasti\u00e0","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Planas-Balagu\u00e9","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Catas\u00fas-Clav\u00e9","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garc\u00eda-Tejedor","sequence":"additional","affiliation":[{"name":", Hospital Universitari Bellvitge, Idibell, Universitat de Barcelona, , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"7","key":"10.3233\/BD-210043_ref1","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1245\/s10434-009-0452-2","article-title":"The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors","volume":"16","author":"Tsai","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.3233\/BD-210043_ref2","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/bjs.9846","article-title":"Adjuvant taxanes and the development of breast cancer-related arm lymphoedema","volume":"102","author":"Cariati","year":"2015","journal-title":"Br J Surg"},{"issue":"1","key":"10.3233\/BD-210043_ref3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10549-007-9710-9","article-title":"Prognosis of the upper limb following surgery and radiation for breast cancer","volume":"110","author":"Lee","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.3233\/BD-210043_ref4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/jso.21435","article-title":"Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study","volume":"101","author":"Yang","year":"2010","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.3233\/BD-210043_ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-019-1243-y","article-title":"Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer \u2013 a long-term observation","volume":"14","author":"Rupp","year":"2019","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.3233\/BD-210043_ref6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/annonc\/mdh019","article-title":"The impact of sentinel node biopsy and axillary staging strategy on hospital costs","volume":"15","author":"R\u00f3nk\u00e1","year":"2004","journal-title":"Ann Oncol"},{"issue":"9","key":"10.3233\/BD-210043_ref7","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s00520-018-4186-1","article-title":"Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB","volume":"26","author":"Belmonte","year":"2018","journal-title":"Support Care Cancer"},{"issue":"1\u20132","key":"10.3233\/BD-210043_ref8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000111085","article-title":"Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years","volume":"72","author":"Dom\u00e8nech","year":"2007","journal-title":"Oncology"},{"key":"10.3233\/BD-210043_ref9","doi-asserted-by":"publisher","first-page":"P927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.3233\/BD-210043_ref11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000499931","article-title":"St. Gallen\/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment","volume":"14","author":"Balic","year":"2019","journal-title":"Breast Care"},{"issue":"6","key":"10.3233\/BD-210043_ref12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/2000656X.2012.714785","article-title":"Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment","volume":"46","author":"Brorson","year":"2012","journal-title":"J Plast Surg Hand Surg"},{"key":"10.3233\/BD-210043_ref13","doi-asserted-by":"publisher","DOI":"10.1063\/1.4704591"},{"key":"10.3233\/BD-210043_ref14","doi-asserted-by":"publisher","first-page":"CD003475","DOI":"10.1002\/14651858.CD003475.pub2","article-title":"Manual lymphatic drainage for lymphedema following breast cancer treatment","volume":"5","author":"Ezzo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/BD-210043_ref15","first-page":"170","article-title":"The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology","volume":"49","author":"Society","year":"2016","journal-title":"Acta Angiol"},{"key":"10.3233\/BD-210043_ref16","unstructured":"Lymphoedema Framework. Best Practice for the Management of Lymphoedema, 60: 2006."},{"issue":"3","key":"10.3233\/BD-210043_ref17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1026564723698","article-title":"Long-term morbidity following axillary dissection in breast cancer patients \u2013 clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors","volume":"64","author":"Kuehn","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210043_ref18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.canrad.2018.06.012","article-title":"The sentinel lymph node of breast cancer and the radiation oncologist","volume":"22","author":"Hennequin","year":"2018","journal-title":"Cancer\/Radiotherapie"},{"issue":"6","key":"10.3233\/BD-210043_ref19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.3233\/BD-210043_ref20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1089\/lrb.2013.0042","article-title":"Lymphedema predictor factors after breast cancer surgery: a survival analysis","volume":"13","author":"Monleon","year":"2015","journal-title":"Lymphat Res Biol"},{"issue":"30","key":"10.3233\/BD-210043_ref21","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1200\/JCO.2012.41.8574","article-title":"Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review","volume":"30","author":"Paskett","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.3233\/BD-210043_ref22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.ijrobp.2008.02.080","article-title":"Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?","volume":"72","author":"Hayes","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.3233\/BD-210043_ref23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.3233\/BD-210043_ref24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1245\/ASO.2004.04.017","article-title":"Lymphedema secondary to postmastectomy radiation: incidence and risk factors","volume":"11","author":"Hinrichs","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.3233\/BD-210043_ref25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.3233\/BD-210043_ref26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/ejso.2002.1403","article-title":"Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review","volume":"29","author":"Rietman","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.3233\/BD-210043_ref27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10549-006-9339-0","article-title":"Pectoral stretching program for women undergoing radiotherapy for breast cancer","volume":"102","author":"Lee","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210043_ref28","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/j.1365-2648.2010.05374.x","article-title":"Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review","volume":"66","author":"Chan","year":"2010","journal-title":"J Adv Nurs"},{"key":"10.3233\/BD-210043_ref29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-013-2509-y","article-title":"A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection","volume":"139","author":"Kootstra","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.3233\/BD-210043_ref30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.apmr.2013.12.015","article-title":"Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures","volume":"95","author":"Sagen","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.3233\/BD-210043_ref31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1590\/S1413-35552011000200010","article-title":"Functional performance of upper limb and quality of life after sentinel lymph node biopsy of breast cancer\/Desempenho funcional de membros superiores e qualidade de vida ap\u00f3s bi\u00f3psia de linfonodo sentinela para o tratamento do c\u00e2ncer de mama","volume":"15","author":"Velloso","year":"2011","journal-title":"Brazilian J Phys Ther\/Rev Bras Fisioter"},{"issue":"1","key":"10.3233\/BD-210043_ref32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1015234318582","article-title":"Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation","volume":"73","author":"Haid","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.3233\/BD-210043_ref33","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1200\/JCO.2007.14.4899","article-title":"Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function","volume":"26","author":"Hayes","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.3233\/BD-210043_ref34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1158\/1055-9965.EPI-06-0168","article-title":"The epidemiology of arm and hand swelling in premenopausal breast cancer survivors","volume":"16","author":"Paskett","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3233\/BD-210043_ref35","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.231"},{"key":"10.3233\/BD-210043_ref36","doi-asserted-by":"publisher","first-page":"P102","DOI":"10.1016\/j.breast.2016.07.021","article-title":"Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: a one year follow-up study","volume":"29","author":"De Groef","year":"2016","journal-title":"Breast"},{"issue":"5","key":"10.3233\/BD-210043_ref37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/qjmed\/hci053","article-title":"Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study","volume":"98","author":"Clark","year":"2005","journal-title":"QJM \u2013 Mon J Assoc Physicians"},{"issue":"11","key":"10.3233\/BD-210043_ref38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/j.1365-2702.2007.02187.x","article-title":"Incidence and risk factors of breast cancer lymphoedema","volume":"17","author":"Park","year":"2008","journal-title":"J Clin Nurs"},{"key":"10.3233\/BD-210043_ref39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11764-010-0156-4","article-title":"The relation between arm\/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study","volume":"5","author":"Nesvold","year":"2011","journal-title":"J Cancer Surviv"},{"key":"10.3233\/BD-210043_ref40","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000003491"},{"issue":"3","key":"10.3233\/BD-210043_ref41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12282-018-0830-3","article-title":"The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study","volume":"25","author":"Zou","year":"2018","journal-title":"Breast Cancer"},{"issue":"1","key":"10.3233\/BD-210043_ref42","first-page":"33","article-title":"The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer","volume":"110","author":"Rebegea","year":"2015","journal-title":"Chir"},{"issue":"29","key":"10.3233\/BD-210043_ref43","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.3233\/BD-210043_ref44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study","volume":"88","author":"Warren","year":"2015","journal-title":"Institutes \\unskip\\break Nac Heal"},{"issue":"1","key":"10.3233\/BD-210043_ref45","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ijrobp.2014.06.024","article-title":"The impact of radiation therapy on lymphedema risk and the agreement between subjective and objective lymphedema measures: NSABP B-32 secondary data analysis","volume":"90","author":"McCloskey","year":"2014","journal-title":"Int J Radiat Oncol"},{"issue":"4","key":"10.3233\/BD-210043_ref46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/lrb.2014.0030","article-title":"Lymphedema following taxane-based chemotherapy in women with early breast cancer","volume":"12","author":"Lee","year":"2014","journal-title":"Lymphat Res Biol"},{"issue":"3","key":"10.3233\/BD-210043_ref47","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.3233\/BD-210043_ref48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10549-015-3408-1","article-title":"Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema: results from a large prospective cohort","volume":"151","author":"Swaroop","year":"2015","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-210043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:21Z","timestamp":1777383141000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-210043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":47,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/bd-210043","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]}}}